Bloomage BioTechnology Corporation Limited (SHA:688363)

-13.99% (1Y)

Market Cap	24.65B
Revenue (ttm)	5.09B
Net Income (ttm)	32.79M
Shares Out	478.36M
EPS (ttm)	0.07
PE Ratio	751.53
Forward PE	48.03
Dividend	0.11 (0.21%)
Ex-Dividend Date	Aug 8, 2024

Volume	2,101,003
Average Volume	2,438,980
Open	51.35
Previous Close	51.30
Day's Range	51.07 - 51.76
52-Week Range	42.51 - 84.59
Beta	0.70
RSI	50.62
Earnings Date	Aug 27, 2025

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 4,444
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.